Introduction to SmartScan's New Service
On June 17, 2023, SmartScan Co., Ltd., a wholly-owned subsidiary of Eucalia, officially launched its new service, the "Colon CT Cancer Dock," at the Tatebayashi Memorial Hospital in Gunma Prefecture. The initiative aims to promote early detection of colon cancer, a disease that significantly impacts health in Japan. The service allows patients to undergo CT exams without the need for prior laxative preparations. This innovative approach is designed to minimize discomfort while maximizing the effectiveness of the screening process.
Features of the Colon CT Cancer Dock
The newly introduced Colon CT Cancer Dock offers numerous advantages:
1.
No Laxative Requirement: Patients can effectively prepare for their exams without the discomfort of taking laxatives.
2.
AI Imaging Analysis: The examination process involves advanced imaging technology, which includes the use of artificial intelligence to analyze CT images for detecting potential cancerous growths and polyps. The imaging results will be interpreted by Boston Medical Science Co., Ltd., known for its pioneering development of non-invasive colon cancer screening solutions.
3.
Convenient Online Access: Patients can easily book their appointments online and view their results via a personalized web dashboard. This feature enhances accessibility, ensuring that individuals can take charge of their health from the comfort of their homes.
Why Early Detection is Critical
Colon cancer ranks as the second highest among cancer incidence rates in Japan, while it is the leading cause of cancer deaths among women. Expedited diagnosis and treatment are crucial for improving survival rates. Given that early-stage colon cancer often presents without clear symptoms, regular screenings become imperative for proactive health management.
Through this collaboration between SmartScan, Tatebayashi Memorial Hospital, and Boston Medical Science, the aim is to provide more people with access to screenings that have considerably lower physical burdens. By doing so, these organizations hope to contribute to early cancer detection and subsequent treatment, ultimately reducing the number of fatalities associated with this preventable disease.
About SmartDock
The Colon CT Cancer Dock is part of SmartDock, a service provided by SmartScan that seeks to optimize the use of advanced medical imaging technologies, including MRI and CT scans. By utilizing IT solutions, SmartDock provides diagnostic services at affordable prices across Japan without compromising quality. The program has already garnered substantial public endorsement, with over 157,000 screenings completed by May 2025.
In addition to the Colon CT Cancer Dock, SmartDock offers a wealth of other cancer screening options, such as:
- - Smart Brain Dock
- - Pancreatic Cancer Dock
- - Pelvic Cancer Dock (including gynecological and prostate screenings)
- - Chest CT Lung Dock
Eucalia's Vision in Healthcare
the prevention and early detection of diseases plays a pivotal role in extending the health span of individuals, especially in an aging society like Japan. Eucalia's approach to healthcare DX (digital transformation) aligns with their vision to industrialize healthcare while achieving stability across medical and caregiving facilities. Their mission revolves around providing superior services that improve well-being for both caregivers and patients, thereby enhancing quality of life.
To achieve these goals, Eucalia is working on enriching its healthcare services, integrating cutting-edge AI technology that supports healthcare providers and patients alike in accessing a variety of health services smoothly and effectively.
SmartScan, along with various collaborative partners, is committed to advancing the understanding and early detection of prevalent healthcare issues. Their ongoing research and development efforts aim to address various challenges faced in the medical domain, ensuring that every citizen benefits from the best health services available.
Conclusion
With innovative services like the Colon CT Cancer Dock, SmartScan is actively contributing to the evolving landscape of healthcare in Japan, enabling more efficient and user-friendly access to essential cancer screenings. Their cooperation with esteemed organizations and their commitment to affordable healthcare ensures that more individuals will take proactive steps toward their health, fostering a culture of preventive healthcare in society. This initiative not only addresses immediate health needs but also paves the way for a more resilient healthcare system in the future.